152 related articles for article (PubMed ID: 11759065)
21. Inhibitory effect of thalidomide on the growth, secretory function and angiogenesis of estrogen-induced prolactinoma in Fischer 344 rats.
Stepień H; Lawnicka H; Mucha S; Wagrowska-Danilewicz M; Stepień B; Siejka A; Komorowski J
Life Sci; 2006 Sep; 79(18):1741-8. PubMed ID: 16846617
[TBL] [Abstract][Full Text] [Related]
22. Spontaneous prolactin transplantable tumor in the Wistar/Furth rat (SMtTW): a new animal model of human prolactinoma.
Trouillas J; Girod C; Claustrat B; Joly-Pharaboz MO; Chevallier P
Cancer Res; 1990 Jul; 50(13):4081-6. PubMed ID: 2354457
[TBL] [Abstract][Full Text] [Related]
23. Interactions of steroids with prolactin secretion in vitro.
Lamberts SW
Horm Res; 1985; 22(3):172-8. PubMed ID: 4054837
[TBL] [Abstract][Full Text] [Related]
24. [Expression of prolactin, TGF alpha and TGF beta 1 genes in estrogen-induced eutopic and ectopic pituitary prolactin-secreting tumors of rats].
Wu XM; Xu JP; Zhang R; Xu RK
Sheng Li Xue Bao; 1999 Dec; 51(6):675-80. PubMed ID: 11498938
[TBL] [Abstract][Full Text] [Related]
25. Estrogen receptor expression in human pituitary: correlation with immunohistochemistry in normal tissue, and immunohistochemistry and morphology in macroadenomas.
Friend KE; Chiou YK; Lopes MB; Laws ER; Hughes KM; Shupnik MA
J Clin Endocrinol Metab; 1994 Jun; 78(6):1497-504. PubMed ID: 7515390
[TBL] [Abstract][Full Text] [Related]
26. Giant prolactinoma: where's the prolactin?
Tailor C; Teo I; Sorisky A
Clin Neurol Neurosurg; 2011 Nov; 113(9):810-2. PubMed ID: 21906866
[No Abstract] [Full Text] [Related]
27. In vitro and in vivo herpetic vector-mediated gene transfer in the pituitary gland: impact on hormone secretion.
Bolognani F; Albariño C; Romanowski V; Carri NG; Goya RG
Eur J Endocrinol; 2001 Oct; 145(4):497-503. PubMed ID: 11581010
[TBL] [Abstract][Full Text] [Related]
28. Estrogen receptors are involved in xenoestrogen induction of growth hormone in the rat pituitary gland.
Dang VH; Choi KC; Jeung EB
J Reprod Dev; 2009 Apr; 55(2):206-13. PubMed ID: 19145065
[TBL] [Abstract][Full Text] [Related]
29. [Melatonin inhibits the proliferation of pituitary prolactin-secreting tumor by suppressing the enhancer elements mutation of PRL gene in the rat].
Gao L; Yang QH; Xu RK
Sheng Li Xue Bao; 2005 Jun; 57(3):319-27. PubMed ID: 15968426
[TBL] [Abstract][Full Text] [Related]
30. In vivo and in vitro effects of octreotide, quinagolide and cabergoline in four hyperprolactinaemic acromegalics: correlation with somatostatin and dopamine D2 receptor scintigraphy.
Ferone D; Pivonello R; Lastoria S; Faggiano A; Del Basso de Caro ML; Cappabianca P; Lombardi G; Colao A
Clin Endocrinol (Oxf); 2001 Apr; 54(4):469-77. PubMed ID: 11318782
[TBL] [Abstract][Full Text] [Related]
31. DNA synthesis by pituitary tumours, with reference to plasma hormone levels and to effects of bromocriptine.
Lloyd HM; Jacobi JM; Willgoss DA
Clin Endocrinol (Oxf); 1995 Jul; 43(1):79-85. PubMed ID: 7641414
[TBL] [Abstract][Full Text] [Related]
32. In vivo effect of cabergoline, a dopamine agonist, on estrogen-induced rat pituitary tumors.
Eguchi K; Kawamoto K; Uozumi T; Ito A; Arita K; Kurisu K
Endocr J; 1995 Apr; 42(2):153-61. PubMed ID: 7627259
[TBL] [Abstract][Full Text] [Related]
33. Role of the pituitary in tumor promotion with ethinyl estradiol in rat liver.
Hallstrom IP; Liao DZ; Assefaw-Redda Y; Ohlson LC; Sahlin L; Eneroth P; Eriksson LC; Gustafsson JA; Blanck A
Hepatology; 1996 Oct; 24(4):849-54. PubMed ID: 8855187
[TBL] [Abstract][Full Text] [Related]
34. Growth hormone and prolactin responses to corticotrophin-releasing-hormone in patients with Cushing's disease: a paracrine action of the adenomatous corticotrophic cells?
Loli P; Boccardi E; Branca V; Bramerio M; Barberis M; Losa M; Terreni MT; Lodrini S; Pollo B; Vignati F
Clin Endocrinol (Oxf); 1998 Oct; 49(4):433-9. PubMed ID: 9876339
[TBL] [Abstract][Full Text] [Related]
35. The effects of estrogens on tumor growth and on prolactin and growth hormone mRNA expression in rat pituitary tissues.
Lloyd RV; Cano M; Landefeld TD
Am J Pathol; 1988 Nov; 133(2):397-406. PubMed ID: 2461092
[TBL] [Abstract][Full Text] [Related]
36. Effects of 17 beta-estradiol and medroxyprogesterone acetate upon MtTW15 mammosomatotropic pituitary tumor growth and hormone production in male and female rats.
Winneker RC; Parsons JA
Cancer Res; 1981 May; 41(5):1772-7. PubMed ID: 7214344
[TBL] [Abstract][Full Text] [Related]
37. Effects of bromocriptine on serum prolactin levels, pituitary weight and immunoreactive prolactin cells in estradiol-treated ovariectomized rats: an experimental model of estrogen-dependent hyperprolactinemia.
Ribeiro MF; Spritzer PM; Barbosa-Coutinho LM; Oliveira MC; Pavanato MA; Silva IS; Reis FM
Braz J Med Biol Res; 1997 Jan; 30(1):113-7. PubMed ID: 9222412
[TBL] [Abstract][Full Text] [Related]
38. Endocrinological outcome following first time transsphenoidal surgery for GH-, ACTH-, and PRL-secreting pituitary adenomas.
Kristof RA; Schramm J; Redel L; Neuloh G; Wichers M; Klingmüller D
Acta Neurochir (Wien); 2002 Jun; 144(6):555-61; discussion 561. PubMed ID: 12111488
[TBL] [Abstract][Full Text] [Related]
39. Suppression of MMQ cells by fulvestrant: possible mechanism of action and potential application for bromocriptine-resistant prolactinomas.
Bai J; Gui S; Zhang Y
J Clin Neurosci; 2013 May; 20(5):721-5. PubMed ID: 23523357
[TBL] [Abstract][Full Text] [Related]
40. TLR4 inhibition suppresses growth in oestrogen-induced prolactinoma models.
Zhang Y; Ma L; Dong S; Ding Q; Wang S; Wu Q; Ni P; Zhang H; Chen Y; Wu J; Wang X
Endocr Relat Cancer; 2022 Dec; 29(12):703-716. PubMed ID: 36219868
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]